Related Experiment Video
Updated: Apr 19, 2026
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
30.0K
An overview of vortioxetine
The Journal of Clinical Psychiatry
|January 1, 2015
Summary
Vortioxetine, a novel antidepressant, is approved for major depressive disorder. Clinical trials show its efficacy and favorable safety profile, improving patient compliance.
Area of Science:
- Pharmacology
- Neuroscience
- Clinical Medicine
Background:
- Major depressive disorder (MDD) is a prevalent and debilitating condition.
- Existing antidepressants have limitations in efficacy and tolerability.
- There is a need for novel therapeutic options for MDD.
Purpose of the Study:
- To provide an overview of vortioxetine, a new serotonergic antidepressant.
- To discuss the pharmacologic profile and receptor-mediated effects of vortioxetine.
- To summarize clinical trial data on vortioxetine's efficacy, safety, and tolerability.
Main Methods:
- Review of pharmacologic data and receptor-binding studies.
- Summary of findings from pivotal clinical trials in adult patients with MDD.
- Analysis of safety and tolerability data relevant to patient compliance.
Main Results:
- Vortioxetine exhibits a multimodal mechanism of action, including serotonin reuptake inhibition and direct receptor modulation.
- Clinical trials demonstrate vortioxetine's statistically significant efficacy in treating major depressive disorder compared to placebo.
- Vortioxetine is generally well-tolerated, with a safety profile that supports patient adherence.
Conclusions:
- Vortioxetine represents a new treatment option for adults with major depressive disorder.
- Its unique pharmacologic profile may contribute to its clinical effectiveness.
- Favorable safety and tolerability are important considerations for patient compliance with vortioxetine therapy.
More Related Videos
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
1.7K
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
745
Related Concept Videos
01:25Antidepressant Drugs: Overview
2.2K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.2K
01:23Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
01:26Anxiolytic Drugs: Overview
1.6K
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
1.6K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.3K
01:18Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
01:28Psychosis and Antipsychotic Drugs: Overview
1.2K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.2K